The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study

BioFactors

Volumn 38, Issue 6, 2012, Pages 416-421

  Mezawa, Morito ^a,b   Takemoto, Minoru ^a,b   Onishi, Shunichiro ^a,b   Ishibashi, Ryoichi ^a,b   Ishikawa, Takahiro ^a,b   Yamaga, Masaya ^b   Fujimoto, Masaki ^a,b   Okabe, Emiko ^a,b   He, Peng ^a   Kobayashi, Kazuki ^a,b   Yokote, Koutaro ^a,b  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Coenzyme Q10; Insulin secretion; Ubiquinol

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; EZETIMIBE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; PIOGLITAZONE; SULFONYLUREA; TRIACYLGLYCEROL; UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; INSULIN RELEASE; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; OXIDATIVE STRESS; PILOT STUDY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; PILOT PROJECTS; UBIQUINONE;

EID: 84871205114     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1038     Document Type: Article

References (27)

1. Villalba, J. M., Parrado, C., Santos-Gonzalez, M., and Alcain, F. J. (2010) Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. Exp. Opin. Invest. Drugs. 19, 535-554.
2. Miles, M. V., Horn, P. S., Morrison, J. A., Tang, P. H., DeGrauw, T., and Pesce, A. J. (2003) Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin. Chim. Acta. 332, 123-132.
3. Kalen, A., Appelkvist, E. L., and Dallner, G. (1989) Age-related changes in the lipid compositions of rat and human tissues. Lipids 24, 579-584.
4. Lim, S. C., Tan, H. H., Goh, S. K., Subramaniam, T., Sum, C. F., Tan, I. K., Lee, B. L., and Ong, C. N. (2006) Oxidative burden in prediabetic and diabetic individuals: Evidence from plasma coenzyme Q(10). Diabet. Med. 23, 1344-1349.
5. Bonnefont-Rousselot, D., Bastard, J. P., Jaudon, M. C., and Delattre, J. (2000) Consequences of the diabetic status on the oxidant/antioxidant balance. Diabet. Metab. 26, 163-176.
6. West, I. C. (2000) Radicals and oxidative stress in diabetes. Diabet Med. 17, 171-180.
7. Golbidi, S., Ebadi, S. A., and Laher, I. (2011) Antioxidants in the treatment of diabetes. Curr Diabetes Rev. 7, 106-125.
8. Giacco, F. and Brownlee, M. (2010) Oxidative stress and diabetic complications. Circ Res. 107, 1058-1070.
9. Baggio, E., Gandini, R., Plancher, A. C., Passeri, M., and Carmosino, G. (1994) Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators. Mol Aspects Med. 15, s287-s294.
10. Langsjoen, P. H. and Langsjoen, A. M. (2008) Supplemental ubiquinol in patients with advanced congestive heart failure. Biofactors. 32, 119-128.
11. Shults, C. W., Oakes, D., Kieburtz, K., Beal, M. F., Haas, R., Plumb, S., Juncos, J. L., Nutt, J., Shoulson, I., Carter, J., Kompoliti, K., Perlmutter, J. S., Reich, S., Stern, M., Watts, R. L., Kurlan, R., Molho, E., Harrison, M., and Lew, M. (2002) Effects of coenzyme Q10 in early Parkinson disease: Evidence of slowing of the functional decline. Arch Neurol. 59, 1541-1550.
12. Muller, T., Buttner, T., Gholipour, A. F., and Kuhn, W. (2003) Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease. Neurosci Lett. 341, 201-204.
13. Choi, H. K., Pokharel, Y. R., Lim, S. C., Han, H. K., Ryu, C. S., Kim, S. K., Kwak, M. K., and Kang, K. W. (2009) Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression. Toxicol. Appl. Pharmacol. 240, 377-384.
14. Miles, M. V., Patterson, B. J., Chalfonte-Evans, M.L., Miles, M. V., Patterson, B. J., Chalfonte-Evans, M. L., Horn, P. S., Hickey, F. J., Schapiro, M. B., Steele, P. E., Tang, P. H., and Hotze, S. L. (2007) Coenzyme Q10 (ubiquinol-10) supplementation improves oxidative imbalance in children with trisomy 21. Pediatr Neurol. 37, 398-403.
15. Crane, F. L. (2001) Biochemical functions of coenzyme Q10. J Am Coll Nutr. 20, 591-598.
16. Bentinger, M., Brismar, K., and Dallner, G. (2007) The antioxidant role of coenzyme Q. Mitochondrion. 7, S41-S50.
17. Turunen, M., Appelkvist, E. L., Sindelar, P., and Dallner, G. (1999) Blood concentration of coenzyme Q(10) increases in rats when esterified forms are administered. J. Nutr. 129, 2113-2118.
18. Ceriello, A. and Motz, E. (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol. 24, 816-823.
19. Kaneto, H., Fujii, J., Myint, T., Miyazawa, N., Islam, K. N., Kawasaki, Y., Suzuki, K., Nakamura, M., Tatsumi, H., Yamasaki, Y., and Taniguchi, N. (1996) Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem. J. 320, 855-863.
20. Rahimi, R., Nikfar, S., Larijani, B., and Abdollahi, M. (2005) A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother. 59, 365-373.
21. Kishi, T., Kishi, H., Watanabe, T., and Folkers, K. (1976) Bioenergetics in clinical medicine. XI. Studies on coenzyme Q and diabetes mellitus. J Med. 7, 307-321.
22. Eriksson, J. G., Forsen, T. J., Mortensen, S. A., and Rohde, M. (1999) The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus. Biofactors. 9, 315-318.
23. Henriksen, J. E., Andersen, C. B., Hother-Nielsen, O., Vaag, A., Mortensen, S. A., and Beck-Nielsen, H. (1999) Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus. Diabet Med. 16, 312-318.
24. Hodgson, J. M., Watts, G. F., Playford, D. A., Burke, V., Croft, K. D. (2002) Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur. J. Clin. Nutr. 56, 1137-1142.
25. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature. 414, 813-820.
26. Bessler, H., Bergman, M., Blumberger, N., Djaldetti, M., and Salman, H. (2010) Coenzyme Q10 decreases TNF-alpha and IL-2 secretion by human peripheral blood mononuclear cells. J. Nutr. Sci. Vitaminol. 56, 77-81.
27. McCarty, M. F. (1999) Can correction of sub-optimal coenzyme Q status improve beta-cell function in type II diabetics? Med. Hypotheses. 52, 397-400.